These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma. Röder C; Trauzold A; Kalthoff H Eur J Cell Biol; 2011; 90(6-7):450-5. PubMed ID: 21129814 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis pathways and their therapeutic exploitation in pancreatic cancer. Fulda S J Cell Mol Med; 2009 Jul; 13(7):1221-7. PubMed ID: 19382915 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis. Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665 [TBL] [Abstract][Full Text] [Related]
6. New aspects of regulatory signaling pathways and novel therapies in pancreatic cancer. Diamantidis M; Tsapournas G; Kountouras J; Zavos C Curr Mol Med; 2008 Feb; 8(1):12-37. PubMed ID: 18289011 [TBL] [Abstract][Full Text] [Related]
7. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells. Wang H; Cai J; Du S; Guo Z; Xin B; Wang J; Wei W; Shen X Cell Biochem Funct; 2017 Aug; 35(6):315-326. PubMed ID: 28845524 [TBL] [Abstract][Full Text] [Related]
8. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. Greenhough A; Patsos HA; Williams AC; Paraskeva C Int J Cancer; 2007 Nov; 121(10):2172-80. PubMed ID: 17583570 [TBL] [Abstract][Full Text] [Related]
9. Signal transduction in human pancreatic cancer: roles of transforming growth factor beta, somatostatin receptors, and other signal intermediates. Li M; Becnel LS; Li W; Fisher WE; Chen C; Yao Q Arch Immunol Ther Exp (Warsz); 2005; 53(5):381-7. PubMed ID: 16314822 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy. Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Zhu Y; Culmsee C; Klumpp S; Krieglstein J Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283 [TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: involvement of both mitochondrial and death receptor pathways. Costa MA; Fonseca BM; Teixeira NA; Correia-da-Silva G Placenta; 2015 Jan; 36(1):69-76. PubMed ID: 25465706 [TBL] [Abstract][Full Text] [Related]
13. Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway? Kim HR; Kim EJ; Yang SH; Jeong ET; Park C; Lee JH; Youn MJ; So HS; Park R Exp Mol Med; 2006 Dec; 38(6):616-24. PubMed ID: 17202837 [TBL] [Abstract][Full Text] [Related]
14. Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS. Cheng HB; Bo Y; Shen WX; Ren XG; Tan JN; Jia ZR; Xu CL Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):623-34. PubMed ID: 25743573 [TBL] [Abstract][Full Text] [Related]
15. XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis. Ehrenschwender M; Bittner S; Seibold K; Wajant H Cell Death Dis; 2014 Dec; 5(12):e1570. PubMed ID: 25501831 [TBL] [Abstract][Full Text] [Related]
16. Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells. Kim KH; Seo HS; Choi HS; Choi I; Shin YC; Ko SG Arch Pharm Res; 2011 Aug; 34(8):1363-72. PubMed ID: 21910059 [TBL] [Abstract][Full Text] [Related]
17. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches. Eberle J; Kurbanov BM; Hossini AM; Trefzer U; Fecker LF Drug Resist Updat; 2007 Dec; 10(6):218-34. PubMed ID: 18054518 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis-modulating agents in combination with radiotherapy-current status and outlook. Belka C; Jendrossek V; Pruschy M; Vink S; Verheij M; Budach W Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):542-54. PubMed ID: 14751526 [TBL] [Abstract][Full Text] [Related]
19. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811 [TBL] [Abstract][Full Text] [Related]
20. Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells. Fitzgerald TL; Lertpiriyapong K; Cocco L; Martelli AM; Libra M; Candido S; Montalto G; Cervello M; Steelman L; Abrams SL; McCubrey JA Adv Biol Regul; 2015 Sep; 59():65-81. PubMed ID: 26257206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]